Improved in vitro digestibility; exerted GSH-enhancement by the release of novel peptides by gastrointestinal digestive enzymes; showed a trend to decrease interleukin-8 (IL-8) secretion in stimulated CF cells. This evidence concerns the gene CXCL8 and cystic fibrosis.